Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects

ClinicalTrials.gov ID: NCT02150499

Public ClinicalTrials.gov record NCT02150499. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 5:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Safety and Tolerability Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects Birth to ≤ 48 Months of Age With Reactive Airways Disease in an Acute Setting

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a study of levalbuterol tartrate HFA inhalation aerosol MDI in pediatric subjects birth to ≤ 48 months of age who go to the Emergency Department (ED) or their physician's office with an acute bronchospasm. Subjects presenting to the ED or physician's office with an acute bronchospasm must have a history of reactive airways disease, based on subjects' parent/guardian report.

Study identification

NCT ID
NCT02150499
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
18 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Up to 48 Months
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2014 (Type not available)
Primary completion
Dec 2014 (Actual)
Completion
Dec 2014 (Actual)
Last update posted
Apr 8, 2016

2014

United States locations

U.S. sites
17
U.S. states
13
U.S. cities
15
Facility City State ZIP Site status
Score Physician Alliance, LLC St. Petersburg Florida 33710 —
Northern Illinios Research Associates DeKalb Illinois 60115 —
Northern Illinois Associates DeKalb Illinois 60115 —
Michael W. Simon, MD, PSC Nicholasville Kentucky 40356 —
Willis-Knighton Physician Network / Portico Pediatrics Shreveport Louisiana 71105 —
Mid Michigan Sleep Center Grand Blanc Michigan 48439 —
Craig Spiegel, MD Bridgeton Missouri 63044 —
St. Peter's University Hospital New Brunswick New Jersey 08901 —
Capital Pediatrics & Adolescent Center PLLC Raleigh North Carolina 27609 —
Capitol Pediatric & Adolescent Center PLLC Raleigh North Carolina 27609 —
Dayton Clinical Research Dayton Ohio 45406 —
Charleston Allergy & Asthma Research Summerville South Carolina 29485 —
Holston Medical Group Kingsport Tennessee 37660 —
TTS Research Boerne Texas 78006 —
Allergy Asthma Research Institute Waco Texas 76712 —
PI-Coor Clinical Research Burke Virginia 22015 —
Advanced Pediatrics Vienna Virginia 22180 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02150499, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 8, 2016 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02150499 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →